Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Penicillin-binding protein 1A (PBP1A) and Penicillin-binding protein 1B (PBP1B) are essential high-molecular-weight Class A enzymes involved in the final stages of bacterial peptidoglycan biosynthesis [1, 3]. These bifunctional proteins possess both glycosyltransferase activity, which polymerizes glycan strands, and transpeptidase activity, which cross-links peptide side chains to provide structural integrity to the cell wall [7, 10]. In many bacteria, such as Escherichia coli, PBP1A and PBP1B exhibit functional redundancy; while neither is individually essential, the loss of both is lethal to the cell [11, 14]. PBP1A is typically associated with the elongasome complex for cell wall expansion, whereas PBP1B is often localized to the divisome to facilitate cell division [1, 19]. As the primary targets for beta-lactam antibiotics, these proteins are inhibited when the drug covalently binds to the active-site serine of the transpeptidase domain, leading to cell wall weakening and osmotic lysis [6, 9]. Resistance to these agents frequently develops through mutations in the pbp genes (e.g., ponA, ponB) that reduce antibiotic binding affinity or through the enzymatic degradation of drugs by beta-lactamases [1, 15].
Inhibition of the transpeptidase domain through covalent binding to the active-site serine, preventing peptidoglycan cross-linking, and/or inhibition of the glycosyltransferase domain, preventing glycan strand polymerization.
10 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Penicillin-binding protein 1A and Penicillin-binding protein 1B (PBP1A and PBP1B).